By contrast, during the progression of breast cancer to malignant phases, TGF-β elicited tumor-promoting effects by driving the EMT, which enhanced tumor cell migration, invasion, and ultimately metastasis to distant organs [11]. Here, TGFB1 is linked to breast carcinoma.